Asset Details
Do you wish to reserve the book?
Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women
Do you wish to request the book?
Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women
2021
Overview
Population analysis of pharmacokinetic data for five differing dosage forms and routes for dexamethasone and betamethasone in 48 healthy nonpregnant Indian women was performed that accounted for a partial and complex cross-over design. Single doses of 6 mg dexamethasone phosphate (DEX-P), betamethasone phosphate (BET-P), or 1:1 mixture of betamethasone phosphate and acetate (BET-PA) were administered orally (PO) or intramuscularly (IM). Plasma concentrations collected for two periods over 96 h were described with a two-compartment model with differing PO and IM first-order absorption inputs. Clearances and volumes were divided by the IM bioavailability FIM. The homogeneous ages, body weights, and ethnicity of the women obviated covariate analysis. Parameter estimates were obtained by the Laplace estimation method implemented in NONMEM 7.4. Typical values for dexamethasone were clearance (CL/FIM) of 9.29 L/h, steady-state volume (Vss/FIM) of 56.4 L, IM absorption constant kaIM of 0.460 1/h and oral absorption constant (kaPO) of 0.936 1/h. Betamethasone parameters were CL/FIM of 5.95 L/h, Vss/FIM of 72.4 L, kaIM of 0.971 1/h, and kaPO of 1.21 1/h. The PO to IM F values were close to 1.0 for both drugs. The terminal half-lives averaged about 7.5 h for DEX, 17 h for BET, and 78 h for BET from BET-PA with the latter reflecting very slow release of BET from the acetate ester. Overall, BET exhibited slower clearance, larger volume of distribution, faster absorption, and longer persistence than DEX. These data may be useful in considering exposures when substituting one form of corticosteroid for another.
Publisher
Springer Nature B.V
Subject
